Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.
- Published In:
- Journal of neurosurgery, 129(5), 1295-1304 (2018)
- Authors:
- Zhang, Yanlu, Chopp, Michael, Gang Zhang, Zheng, Zhang, Yi, Zhang, Li, Lu, Mei, Zhang, Talan, Winter, Stefan, Brandstätter, Hemma, Mahmood, Asim, Xiong, Ye
- Database ID:
- RPEP-04016
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04016APA
Zhang, Yanlu; Chopp, Michael; Gang Zhang, Zheng; Zhang, Yi; Zhang, Li; Lu, Mei; Zhang, Talan; Winter, Stefan; Brandstätter, Hemma; Mahmood, Asim; Xiong, Ye. (2018). Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.. Journal of neurosurgery, 129(5), 1295-1304. https://doi.org/10.3171/2017.6.JNS171007
MLA
Zhang, Yanlu, et al. "Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injury.." Journal of neurosurgery, 2018. https://doi.org/10.3171/2017.6.JNS171007
RethinkPeptides
RethinkPeptides Research Database. "Prospective, randomized, blinded, and placebo-controlled stu..." RPEP-04016. Retrieved from https://rethinkpeptides.com/research/zhang-2018-prospective-randomized-blinded-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.